KYORIN Pharmaceutical Co., Ltd. (TYO:4569)
Japan · Delayed Price · Currency is JPY 1,092.00
-22.00 (-1.97%)
Aug 4, 2026, 10:04 AM JST
KYORIN Pharmaceutical Market Cap
KYORIN Pharmaceutical has a market cap or net worth of 64.01 billion as of August 3, 2026. Its market cap has decreased by -27.79% in one year.
Market Cap
64.01B
Enterprise Value
70.30B
Revenue
125.68B
Ranking
n/a
PE Ratio
29.46
Stock Price
1,092.00
ChartMarket Cap Chart
Since March 10, 2006, KYORIN Pharmaceutical's market cap has increased from 18.24B to 64.01B, an increase of 250.84%. That is a compound annual growth rate of 6.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 64.01B | -27.51% |
| Dec 30, 2025 | 88.30B | 2.13% |
| Dec 30, 2024 | 86.46B | -15.45% |
| Dec 29, 2023 | 102.26B | 3.75% |
| Dec 30, 2022 | 98.56B | -6.82% |
| Dec 30, 2021 | 105.78B | -4.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Towa Pharmaceutical | 197.16B |
| Sawai Group Holdings | 190.61B |
| Kissei Pharmaceutical | 169.33B |
| Kaken Pharmaceutical | 143.71B |
| Mochida Pharmaceutical | 110.51B |
| Zeria Pharmaceutical | 92.13B |
| ASKA Pharmaceutical Holdings | 61.08B |
| Fuji Pharma | 48.61B |